Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Nike Stock Yields 4% and Could Raise Its Dividend for the 25th Straight Year in 2026fool.com
Shares are on a losing streak, but income investors have a lot to be excited about.
Via The Motley Fool · August 18, 2026
ServiceNow vs. Palantir: Both Sell AI SaaS Platforms to Governments and Enterprises. Here's the Number That Actually Separates Their Growth Rates.fool.com
ServiceNow offers more proven, durable growth, while Palantir offers much higher growth potential.
Via The Motley Fool · August 18, 2026
The Smartest Vanguard ETF to Buy With $1,000 Right Nowfool.com
The Fed, oil prices, and corporate earnings are the catalysts putting this Vanguard fund in a prime position to outperform.
Via The Motley Fool · August 18, 2026
Lear Corp (NYSE:LEA): A Quality Dividend Pick for Income Investorschartmill.com
Via Chartmill · August 18, 2026
Barrick Mining (NYSE:B) Shows High Growth Momentum With a Breakout Setupchartmill.com
Via Chartmill · August 18, 2026
Up More Than 3,400% in the Past 12 Months, Here's Why Sandisk's Stock Could Still Go Higherfool.com
Sandisk recently unveiled a long-term guidance which appears to have investors bullish on its stock again.
Via The Motley Fool · August 18, 2026
Should You Forget Big Banks and Bet on a Fintech Instead?fool.com
Banks bring stability, fintech brings potential upside.
Via The Motley Fool · August 18, 2026
Should You Worry That Another Brinker Executive Sold? Here's What Investors Should Knowfool.com
The majority of this disposition was non-discretionary and tied to tax obligations from a vesting event amid a record Brinker stock surge.
Via The Motley Fool · August 18, 2026
Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipelinemarketbeat.com
Travere Therapeutics (NASDAQ:TVTX) is pursuing growth through expanded use of FILSPARI in rare kidney diseases while advancing a late-stage treatment candidate for classical homocystinuria and building its renal pipeline through the recently in-licensed BTK inhibitor civorebrutinib, Chief Financial
Via MarketBeat · August 18, 2026
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.fool.com
The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.
Via The Motley Fool · August 18, 2026
A Brinker Director Sold Near the Stock's Peak. Here's What to Knowfool.com
One Brinker insider sold shares this past week following a 52% stock rally over the past year.
Via The Motley Fool · August 18, 2026
A Brinker Insider Ended the Day Owning More Stock. Here's What Long-Term Investors Should Knowfool.com
Butler's non-discretionary transaction reduced his direct holdings but left him with 19,064 shares worth $4.55 million.
Via The Motley Fool · August 18, 2026
If I Were in My 20s, I'd Buy This Unstoppable Vanguard ETF and Hold It Foreverfool.com
Investors can reap big rewards over the long term by betting on growth in their younger years.
Via The Motley Fool · August 18, 2026
What Brinker's Cluster of Insider Sales Signals After a Record Stock Surge and Booming Yearfool.com
Fuller's sale follows a 50% one-year stock surge, though routine tax withholding accounted for a significant portion of the activity.
Via The Motley Fool · August 18, 2026
Chili's Marketing Fueled a 71% Sales Run. Its CMO Cashed In Some Stockfool.com
George S. Felix reduced his direct equity holdings following a 50% one-year stock return, retaining 6,293 directly held shares valued at $1.49 million.
Via The Motley Fool · August 18, 2026
Ed Yardeni Just Raised His 2026 Price Target on the S&P 500 to 8,400. 3 Ways The Market Can Get There.fool.com
Yardeni has been bullish on the market for the past several years, nailing most of his calls.
Via The Motley Fool · August 18, 2026
AI In Genomics Market Update: Latest M&A Deals and Partnershipstalkmarkets.com
The convergence of artificial intelligence and genomics is reshaping how researchers sequence, interpret, and act on genetic data. According to Grand View
Via Talk Markets · August 18, 2026
Government-Licensed & ISO-Certified Recruitment Agencytalkmarkets.com
As a trusted overseas employment promoter, Sony Manpower is recognized as one of the best overseas employment agencies in Pakistan. Our direct connections
Via Talk Markets · August 18, 2026
Chili's Operating Chief Sold Into the Recent Rally. Here's What to Knowfool.com
White's disposition comes after a 50% one-year stock rally, though he retains 42,756 directly held shares worth roughly $10.1 million.
Via The Motley Fool · August 18, 2026
Asia Pacific Leads Automatic Fire Ball Extinguisher Market in 2025talkmarkets.com
Fire safety technology is shifting away from reactive suppression toward systems that act the moment a fire starts — without anyone in the room. Automatic
Via Talk Markets · August 18, 2026
Need an E-Commerce App? Can DeviceBee Help as a Mobile App Development Company?talkmarkets.com
Running an online store without a reliable mobile app can make it harder to keep customers engaged. Shoppers expect fast browsing, secure payments, persona
Via Talk Markets · August 18, 2026
Diabetes Center Near Metalkmarkets.com
Looking for a trusted Diabetes Center Near Me? Discover expert diabetes care, personalized treatment, regular monitoring, and practical health guidance. Le
Via Talk Markets · August 18, 2026
Billionaire David Tepper of Appaloosa Slashed His Micron Stake and Piled Into a "Fabulous" AI Stock for a 6th Consecutive Quarterfool.com
Two foundational artificial intelligence (AI) stocks have billionaire David Tepper's undivided attention.
Via The Motley Fool · August 18, 2026
Chili's Parent Just Capped Five Years of Growth. Its CEO Sold Into the Rallyfool.com
Hochman disposed of 100,152 shares through tax withholding and a pre-arranged trading plan.
Via The Motley Fool · August 18, 2026
SpaceX Could Have Been Profitable in Q2 -- But Then AI Happenedfool.com
SpaceX and Starlink combined are profitable businesses. The problem is that they're tied to a money-losing AI program.
Via The Motley Fool · August 18, 2026